Jackie A. Fretz, PhD
Biography
Research & Publications
Locations
Biography
I obtained my BS in Biochemistry and Molecular Biology from the University of New Hampshire, and PhD in Biochemistry from the University of Wisconsin--Madison. My research career has focused on transcriptional regulation of cell fate. This has included NFATc1 in osteoclasts, the Vitamin D Receptor in osteoblasts, and EBF1 in mesenchymal progenitors.
Currently I am investigating the actions of EBF1 in mesenchymal progenitors and perivascular cells. In the bone this involves the actions of EBF1 in the vascular support cells (pericytes) to regulate bone vascularity, anabolism, and adipocyte differentiation. We have identified that the marrow adipocytes are a very different form of fat-storing cell than arises in other anatomical locations. This is primarily highlighted by the different way that these cells rely upon the presence of EBF1. Most interestingly Our investigations have revealed that EBF1 is essential to properly mobilize osteoblast progenitors into the bone lineage in the aging adult skeleton and following injury to mediate repair.
In the kidney EBF1 also participates in regulation of renal development and disease progression through it's ability of mesenchymal cells to modulate the vascularity of the glomerulus. Within the adult kidney podocytes use EBF1 to respond to glomerular injury and propagate sclerosis. Our work in kidney is also tied back to bone through the investigation of the pathology underlying chronic kidney disease-mineral bone disorders including regulation of FGF-23 in early chronic kidney disease.
Education & Training
- Research ScientistYale School of Medicine (2014)
- Postdoctoral FellowshipYale School of Medicine (2011)
- PhDUniversity of Wisconsin-Madison, Biochemistry (2007)
- BSUniversity of New Hampshire, Biochemistry and Molecular Biology (2002)
Activities
- Bone Marrow Sinusoidal Endothelial Cells Induce Fgf23 Expression During Iron Deficiency AnemiaAustin, TX, United States 2022ASBMR Annual Meeting
- Marrow adiposity and vascular morphology are regulated by EBF1 in adult boneMontreal, QC, Canada 2018ASBMR Annual Meeting
- The Tmprss6-/- Mouse Model of Iron Refractory Iron Deficiency Anemia (IRIDA) Exhibits Disrupted Phosphate Homeostasis, Elevated Circulating FGF23 Levels, and Increased Fgf23 Expression in Bone MarrowAtlanta, GA, United States 201759th American Society of Hematology Meeting and Exposition
- Elevations in FGF-23 precede disruptions in either phosphate or iron homeostasis in the EBF1-KO model of renal insufficiencySnowmass, CO, United States 2017Advances in Mineral Metabolism
- Specific deletion of EBF1 within the kidney mesangium results in renal osteodystrophy, growth reduction, and premature deathSeattle, WA, United States 2015Workshop on Kidney and Bone Disorders
- Bone Marrow Adipocyte Differentiation and Linage AllocationSnowmass, CO, United States 2010Advances in Mineral Metabolism
- Early B Cell Factor 1 (EBF1), Osteoblasts, Adipocytes and AnorexiaCarrabassett Valley, ME, United States 2010Annual Winter Meeting, Bone Biology and Clinical Medicine
Honors & Recognition
Award | Awarding Organization | Date |
---|---|---|
ASBMR Mid-Career Travel grant | American Society of Bone and Mineral Research | 2022 |
Travel Award | NIH Workshop, FGF-23: An Interdisciplinary Dialog for Chronic Kidney Diseases | 2017 |
President's Poster Award | American Society of Bone and Mineral Research | 2011 |
John Haddad Young Investigator Award | American Society for Bone and Mineral Research | 2010 |
Young Investigator Award | American Society for Bone and Mineral Research | 2009 |